@article{ab6e59d5b4e644f1a7ec0ac5cf274a95,
title = "What's NEXT for CML-NGS mutation screening",
author = "Naranie Shanmuganathan and Hughes, \{Timothy P.\}",
note = "Funding Information: Conflict-of-interest disclosure: N.S. received honoraria from Novartis and travel and accommodation expenses from Novartis, Gilead, Amgen, and Janssen. T.P.H. has served as a consultant for and has received research funding and honoraria from Novartis and Bristol-Myers Squibb. Prepublished online as Blood First Edition paper, December 26, 2019",
year = "2020",
month = feb,
day = "20",
doi = "10.1182/blood.2019004559",
language = "English",
volume = "135",
pages = "515--516",
journal = "Blood",
issn = "0006-4971",
publisher = "Elsevier B.V.",
number = "8",
}